Related Articles
Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients
Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy
microRNA expression is able to predict response to chemoradiotherapy in rectal cancer
MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
Serum microRNA‑125a‑5p as a potential biomarker of HCV‑associated hepatocellular carcinoma